Your browser doesn't support javascript.
loading
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data.
Welén, Karin; Rosendal, Ebba; Gisslén, Magnus; Lenman, Annasara; Freyhult, Eva; Fonseca-Rodríguez, Osvaldo; Bremell, Daniel; Stranne, Johan; Balkhed, Åse Östholm; Niward, Katarina; Repo, Johanna; Robinsson, David; Henningsson, Anna J; Styrke, Johan; Angelin, Martin; Lindquist, Elisabeth; Allard, Annika; Becker, Miriam; Rudolfsson, Stina; Buckland, Robert; Carlsson, Camilla Thellenberg; Bjartell, Anders; Nilsson, Anna C; Ahlm, Clas; Connolly, Anne-Marie Fors; Överby, Anna K; Josefsson, Andreas.
Afiliación
  • Welén K; Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Rosendal E; Department of Clinical Microbiology, Section of Virology, Umeå University, Umeå, Sweden; The Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden.
  • Gisslén M; Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Lenman A; Department of Clinical Microbiology, Section of Virology, Umeå University, Umeå, Sweden.
  • Freyhult E; Department of Medical Sciences, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  • Fonseca-Rodríguez O; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Bremell D; Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Stranne J; Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Balkhed ÅÖ; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Niward K; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Repo J; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Robinsson D; Department of Urology, Region of Jönköping, Jönköping, Sweden.
  • Henningsson AJ; Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Department of Clinical Microbiology, Region Jönköping County, Jönköping, Sweden.
  • Styrke J; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, Umeå, Sweden.
  • Angelin M; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Lindquist E; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Allard A; Department of Clinical Microbiology, Section of Virology, Umeå University, Umeå, Sweden.
  • Becker M; Department of Clinical Microbiology, Section of Virology, Umeå University, Umeå, Sweden.
  • Rudolfsson S; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, Umeå, Sweden.
  • Buckland R; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, Umeå, Sweden.
  • Carlsson CT; Department of Radiation Sciences, Umeå University, Umeå, Sweden.
  • Bjartell A; Division of Urological Cancers, Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Nilsson AC; Department of Translational Medicine, Infectious Diseases Research Unit, Lund University, Malmö, Sweden.
  • Ahlm C; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Connolly AF; The Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Överby AK; The Laboratory for Molecular Infection Medicine Sweden, Umeå, Sweden; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
  • Josefsson A; Institute of Clinical Sciences, Department of Urology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Surgical and Perioperative Sciences, Urology & Andrology, Umeå University, Umeå, Sweden; Wallenberg Center for Molecular Medicine (WCMM), Umeå University, Umeå,
Eur Urol ; 81(3): 285-293, 2022 03.
Article en En | MEDLINE | ID: mdl-34980495
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Compuestos de Tosilo / Benzamidas / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Antagonistas de Andrógenos / Anilidas / Nitrilos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: Europa Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Compuestos de Tosilo / Benzamidas / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 / Antagonistas de Andrógenos / Anilidas / Nitrilos Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies País/Región como asunto: Europa Idioma: En Revista: Eur Urol Año: 2022 Tipo del documento: Article